What diagnostic tests and treatment can a patient with Clostridioides difficile (C-diff) infection expect upon admission?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Expected Orders Upon Admission for C. difficile Infection

Upon admission with suspected C. difficile infection, expect immediate stool testing using a two-step diagnostic algorithm, contact isolation precautions, discontinuation of non-essential antibiotics, and empiric oral vancomycin 125 mg four times daily if severe disease is suspected. 1, 2

Diagnostic Testing Orders

Stool specimen collection and testing should be ordered immediately for patients with ≥3 unformed stools in 24 hours. 1, 2 The recommended approach is a two-step algorithm: either GDH screening followed by toxin testing, or NAAT (PCR) followed by toxin confirmation, which balances sensitivity (91%) and specificity (98%) while avoiding false positives from asymptomatic colonization. 3, 2

  • Single toxin EIA alone is not recommended due to insufficient sensitivity (70-80%). 3, 2
  • Testing should only be performed on unformed stool samples—testing formed stool leads to false positives and unnecessary treatment. 3, 4
  • In patients with suspected severe CDI complicated by ileus who cannot produce stool, perirectal swabs can be used with PCR testing (95.7% sensitivity, 100% specificity). 4
  • Do not order repeat testing if initial test is negative unless clinical suspicion remains extremely high—repeat stool testing has minimal added value. 5

Laboratory Studies

Complete blood count with differential should be ordered to assess for leukocytosis, which is a marker of severe disease. 6 White blood cell counts can reach leukemoid ranges (≥15,000/mm³ defines severe disease). 7, 6

Comprehensive metabolic panel to evaluate for:

  • Hypoalbuminemia (often overlooked marker of severe disease) 6
  • Electrolyte disturbances including hypokalemia and hypomagnesemia 2
  • Acute kidney injury from dehydration 2

Infection Control Orders

Contact isolation precautions must be implemented immediately upon suspicion, before test results return. 2

Soap and water handwashing orders for all healthcare workers—alcohol-based sanitizers do not inactivate C. difficile spores, and mechanical removal through friction and running water is the only effective method. 1

Medication Orders

Discontinue causative antibiotics if clinically feasible, as continued antibiotic use significantly increases recurrence risk. 1, 2

Treatment Based on Severity:

For mild-to-moderate CDI:

  • Oral metronidazole 500 mg three times daily for 10 days 3, 2
  • OR oral vancomycin 125 mg four times daily for 10 days (preferred if intolerant to metronidazole) 3

For severe CDI (≥10 unformed stools/day OR WBC ≥15,000/mm³):

  • Oral vancomycin 125 mg four times daily for 10-14 days (clinical success rate ~81%) 3, 2, 7

For severe-complicated CDI (hypotension, ileus, megacolon):

  • Oral vancomycin 125-500 mg four times daily 3
  • PLUS vancomycin per rectum 500 mg in 500 mL saline as enema four times daily 3
  • AND/OR metronidazole 500 mg IV every 8 hours 3

Empiric therapy should be started immediately if high suspicion of severe CDI exists, even before test results. 3, 2

Contraindicated Orders

Absolutely do NOT order antiperistaltic agents (loperamide, diphenoxylate) as they worsen disease severity, mask symptoms, and precipitate toxic megacolon by trapping toxins against the colonic wall. 1

  • If symptomatic management is needed, opioids or octreotide can be used as alternatives. 1

Additional Considerations

Proton pump inhibitors should be discontinued if possible, as they increase recurrence risk. 3

Imaging orders (CT abdomen/pelvis) may be needed if severe disease is suspected with ileus, toxic megacolon, or peritoneal signs. 6

Endoscopy is reserved for cases with extremely high clinical suspicion but persistently negative stool tests, or when immediate diagnosis is critical—it has only 51-55% sensitivity for CDAD but can visualize pseudomembranes. 8, 9, 6

Do NOT order "test of cure" after treatment completion, as patients may shed spores for up to 6 weeks after successful treatment. 3, 2

Common Pitfalls to Avoid

  • Testing asymptomatic patients detects colonization rather than infection—only test symptomatic patients with diarrhea. 2, 4, 8
  • Ordering multiple repeat tests when initial testing is negative adds minimal value unless clinical suspicion remains extremely high. 5
  • Continuing slow-release oral medications during active diarrhea—rapid transit time prevents adequate absorption. 2
  • Failing to monitor electrolytes in severe disease—hypomagnesemia and hypokalemia worsen outcomes and contribute to toxic megacolon. 2

References

Guideline

C. difficile Infection Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Treatment of Clostridioides difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

C. difficile Diagnostic Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical recognition and diagnosis of Clostridium difficile infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008

Research

Clostridium difficile-associated diarrhea and colitis.

Infection control and hospital epidemiology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.